In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Zogenix, Inc.. Trade Record

NASDAQ:ZGNX Zogenix, Inc. stock gains 15.39% Exit Jun 22, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart ZGNX May 15, 2018, priceSeries
About Zogenix, Inc.

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. The company's lead product candidate is the ZX008, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome. It also develops Relday, an injectable formulation of risperidone to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in Emeryville, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
96.36
Entry Date
May 15, 2018
Entry Price
39.35
Sell Date
Jun 22, 2018
Sell Price
45.41
Net Gain
15.39%
Hold Time
27 Trading Days